The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201) | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)	Brain Tumor, Primary, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, anaplastic astrocytoma, astrocytoma (excluding glioblastoma), brain cancer, brain disorder, central nervous system cancer, central nervous system disorder, epithelial neoplasm, glioblastoma, glioma, malignant glioma, neoplasm, nervous system disorder, neuroepithelial neoplasm, primitive neuroectodermal tumor	Recruiting	Not stated	2024-02-22		NCT06118723

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Haaglanden Medical Centre	17
Insel Gruppe AG, University Hospital Bern	224
Jasper Gerritsen	5
Massachusetts General Hospital	758
Technical University of Munich	85
Universitaire Ziekenhuizen KU Leuven	262
University Hospital Heidelberg	109
University of California, San Francisco	637

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Erasmus Medical Center	Rotterdam	Netherlands	27
Haaglanden Medical Centre	The Hague	Netherlands	3
Inselspital Universitätsspital Bern	Bern	Switzerland	3
Massachusetts General Hospital	Boston	United States	1015
Technical University Munich	Munich	Germany	3
University Hospitals Leuven	Leuven	Belgium	32
University of California, San Francisco (UCSF)	San Francisco	United States	12
Universitätsklinikum Heidelberg	Heidelberg	Germany	9